Regulatory adverse drug reaction analyses support a temporal increase in psychiatric reactions after initiation of cystic fibrosis combination modulator therapies
In the post-ETI period, psychiatric ADRs are the most prevalent ADR reported via the Yellow Card scheme. Despite an unclear mechanism, there is significant clinical relevance in counselling and monitoring regarding psychiatric effects of CFTR modulator therapy.
Authors
- Freddy Frost (ORCID: https://orcid.org/0000-0002-3902-6502)
- D. Nazareth (ORCID: https://orcid.org/0000-0002-6114-0467)
- Kevin W Southern (ORCID: https://orcid.org/0000-0001-6516-9083)
- Jacob O'Connor
- Dennis Wat
Institutions
- University of Liverpool (GB)
- Liverpool Heart and Chest Hospital NHS Trust (GB)
- Liverpool Heart and Chest Hospital (GB)
- Alder Hey Children's Hospital (GB)
Publication Details
- Journal
- Journal of Cystic Fibrosis
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1016/j.jcf.2024.09.010
- Citations
- 7
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 2.93